The earlier cancer is diagnosed, the greater the chances of curing it
Therefore, it is vital that diagnostic tests are carried out in a coordinated manner and as quickly as possible in order to avoid unnecessary delays. These may include imaging tests, blood tests, taking a biopsy and genetic analyses of tumor tissue or blood samples. 
A genetic diagnosis is key to treatment selection
Another fundamental factor is the accurate characterization of the type of cells which have caused the cancer, since this information allows us to select the most appropriate treatment for each case.

The Anatomical Pathology Service at the Dr. Rosell Oncology Institute is comprised of a team of physicians and technicians trained in diagnosing cancer and who have at their disposal the latest technological advances for arriving at the correct diagnosis.

Diagnostic testing enables non-invasive disease monitoring in real time
In certain cancers such as lung cancer, for a large number of patients it is not possible to obtain sufficient tumor tissue by traditional biopsy techniques to be able to perform vital genetic analyses. Therefore, we have developed a highly sensitive test that can be performed in blood samples from cancer patients to determine exactly which genetic mutations are driving tumor growth and therefore select the most effective targeted treatment.

When taken repeatedly throughout the course of treatment, these “liquid biopsies” allow doctors to monitor the patient’s response in real time and switch treatment if necessary, for example if they become resistant to the treatment.
Measuring response in this way allows doctors to anticipate how the disease will develop and act quickly, increasing life expectancy.